Show Summary Details
Page of

Tumors of the Central Nervous System 

Tumors of the Central Nervous System
Chapter:
Tumors of the Central Nervous System
Author(s):

Katherine E. Warren

DOI:
10.1093/med/9780199335114.003.0006
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 April 2021

Tumors of the central nervous system (CNS) are the most common solid tumors of childhood, with approximately 4,000 children diagnosed with a malignant or nonmalignant CNS tumor each year. Pediatric CNS tumors are a heterogeneous group of diseases, varying in their histology, location, biology, prognosis and treatment approach. Location of the tumor is important because it defines the area of the brain involved and the subsequent function affected. Modalities for treatment of CNS tumors include surgery, radiation and chemotherapy. Almost all survivors of pediatric CNS tumors will have long-term effects from the tumor and its treatment. Web resources, such as the CureSearch website (www.curesearch.com) and the Children’s Oncology Group’s Long-Term Follow-up Guidelines are now available as excellent resources to clinicians and parents alike to provide answers to many of the questions that arise regarding late effects in brain tumor survivors.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.